Defining today’s AD and MCI management
Defining Alzheimer’s Disease and MCI Management in the Modern Era

Released: October 31, 2023

Richard Isaacson
Richard Isaacson, MD
Marwan Noel Sabbagh
Marwan Noel Sabbagh, MD, FAAN, FANA

Activity

Progress
1
Course Completed

In this episode, Drs. Sabbagh and Isaacson discuss how to best approach Alzheimer’s disease (AD) and mild cognitive impairment (MCI) in clinical practice, including accurately diagnosing patients and optimizing treatment in terms of patient preferences and reimbursement options. The full episode covers:

  • Defining AD and MCI and their clinical presentation
  • How to diagnose AD vs MCI
  • Reimbursement landscape for current diagnosing and monitoring tools
  • Precision medicine’s evolving role in diagnosing and treating patients with AD and/or MCI